Georg Greiner

14PUBLICATIONS
51CO-AUTHORS
Haematological tumoursRespiratory diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 24, 2023
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.

Georg Greiner, Nadine Witzeneder, Klara Klein

|Feb 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik

|Jan 02, 2023
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.

Irene Graf, Georg Greiner, Rodrig Marculescu

|Jul 09, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

Mathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl

|Jul 07, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.

Barbara Peter, Gregor Eisenwort, Irina Sadovnik

|Jul 03, 2021
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.

Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska

Pageof 3

Frequent Collaborators

8 joint publications

Peter Valent

5 joint publications

Gregor Hoermann

5 joint publications

Gregor Eisenwort

3 joint publications

Wolfgang R Sperr